SIMILAR PATTERNS OF AMINO ACIDS FOR 4RN6_B_15UB301_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1a0j TRYPSIN

(Salmo salar) 		PF00089
(Trypsin) 		6 HIS A  57
LEU A  99
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 SO4  A 248 (-3.9A)
None
None
None
BEN  A 246 ( 3.9A)
BEN  A 246 (-3.3A)
 0.33A 4rn6B-1a0jA:
28.3		 4rn6B-1a0jA:
37.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bqy PLASMINOGEN
ACTIVATOR

(Trimeresurus
stejnegeri) 		PF00089
(Trypsin) 		5 HIS A  57
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 0GJ  A   1 ( 2.7A)
None
None
0GJ  A   1 (-3.5A)
0GJ  A   1 ( 4.3A)
 0.38A 4rn6B-1bqyA:
27.4		 4rn6B-1bqyA:
29.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dlk THROMBIN HEAVY CHAIN

(Bos taurus) 		PF00089
(Trypsin) 		5 HIS B  57
VAL B 213
TRP B 215
GLY B 216
GLY B 226
 None
 0.24A 4rn6B-1dlkB:
29.3		 4rn6B-1dlkB:
35.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1elv COMPLEMENT C1S
COMPONENT

(Homo sapiens) 		PF00084
(Sushi)
PF00089
(Trypsin) 		5 HIS A 460
VAL A 638
TRP A 640
GLY A 641
GLY A 648
 SO4  A2001 ( 3.9A)
None
None
None
None
 0.50A 4rn6B-1elvA:
28.1		 4rn6B-1elvA:
30.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ept PORCINE E-TRYPSIN

(Sus scrofa) 		PF00089
(Trypsin) 		6 HIS A  57
LEU B  99
VAL C 213
TRP C 215
GLY C 216
GLY C 226
 None
 0.41A 4rn6B-1eptA:
undetectable		 4rn6B-1eptA:
15.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1fxy COAGULATION FACTOR
XA-TRYPSIN CHIMERA

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS A  57
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 0G6  A   1 (-2.7A)
None
None
0G6  A   1 (-3.9A)
0G6  A   1 (-3.3A)
 0.36A 4rn6B-1fxyA:
27.3		 4rn6B-1fxyA:
36.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1gvl KALLIKREIN 6

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS A  57
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
 0.52A 4rn6B-1gvlA:
23.7		 4rn6B-1gvlA:
34.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1h4w TRYPSIN IVA

(Homo sapiens) 		PF00089
(Trypsin) 		6 HIS A  57
LEU A  99
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
None
None
None
BEN  A 250 (-3.9A)
BEN  A 250 (-3.3A)
 0.34A 4rn6B-1h4wA:
28.8		 4rn6B-1h4wA:
36.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1h9h TRYPSIN

(Sus scrofa) 		PF00089
(Trypsin) 		6 HIS E  57
LEU E  99
VAL E 213
TRP E 215
GLY E 216
GLY E 226
 None
 0.31A 4rn6B-1h9hE:
28.1		 4rn6B-1h9hE:
38.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1id5 THROMBIN

(Bos taurus) 		PF00089
(Trypsin) 		6 HIS H  57
ALA H 190
VAL H 213
TRP H 215
GLY H 216
GLY H 226
 None
 0.73A 4rn6B-1id5H:
35.7		 4rn6B-1id5H:
87.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1id5 THROMBIN

(Bos taurus) 		PF00089
(Trypsin) 		5 LEU H  99
ALA H 190
VAL H 213
GLY H 216
GLY H 226
 None
 0.88A 4rn6B-1id5H:
35.7		 4rn6B-1id5H:
87.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1j17 TRYPSIN II, ANIONIC

(Rattus
norvegicus) 		PF00089
(Trypsin) 		6 HIS T  57
ALA T 190
VAL T 213
TRP T 215
GLY T 216
GLY T 226
 SO4  T 600 (-3.8A)
ZEN  T   1 (-3.8A)
ZEN  T   1 (-4.1A)
ZEN  T   1 (-3.4A)
ZEN  T   1 (-3.7A)
ZEN  T   1 (-3.7A)
 0.72A 4rn6B-1j17T:
28.7		 4rn6B-1j17T:
37.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1kig FACTOR XA

(Bos taurus) 		PF00089
(Trypsin) 		6 HIS H  57
ALA H 190
VAL H 213
TRP H 215
GLY H 216
GLY H 226
 None
 0.60A 4rn6B-1kigH:
29.5		 4rn6B-1kigH:
39.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1mbq TRYPSIN

(Oncorhynchus
keta) 		PF00089
(Trypsin) 		5 HIS A  57
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
None
None
BEN  A1222 (-3.9A)
BEN  A1222 (-3.4A)
 0.33A 4rn6B-1mbqA:
28.3		 4rn6B-1mbqA:
37.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1mkx PRETHROMBIN-2

(Bos taurus) 		PF00089
(Trypsin)
PF09396
(Thrombin_light) 		5 HIS K  57
TYR K  60
TRP K  60
ALA K 190
VAL K 213
 None
 0.75A 4rn6B-1mkxK:
42.9		 4rn6B-1mkxK:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1mkx PRETHROMBIN-2

(Bos taurus) 		PF00089
(Trypsin)
PF09396
(Thrombin_light) 		6 HIS K  57
TYR K  60
TRP K  60
LEU K  99
TRP K 215
GLY K 216
 None
 0.78A 4rn6B-1mkxK:
42.9		 4rn6B-1mkxK:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1mkx PRETHROMBIN-2

(Bos taurus) 		PF00089
(Trypsin)
PF09396
(Thrombin_light) 		7 HIS K  57
TYR K  60
TRP K  60
LEU K  99
VAL K 213
TRP K 215
GLY K 226
 None
 0.45A 4rn6B-1mkxK:
42.9		 4rn6B-1mkxK:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1o5f SERINE PROTEASE
HEPSIN

(Homo sapiens) 		PF00089
(Trypsin) 		6 HIS H  57
ALA H 190
VAL H 213
TRP H 215
GLY H 216
GLY H 226
 CR9  H 256 (-3.9A)
CR9  H 256 (-2.9A)
CR9  H 256 (-4.3A)
None
CR9  H 256 ( 3.8A)
CR9  H 256 (-3.0A)
 0.66A 4rn6B-1o5fH:
29.9		 4rn6B-1o5fH:
39.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1pq5 TRYPSIN

(Fusarium
oxysporum) 		PF00089
(Trypsin) 		5 HIS A  56
VAL A 210
TRP A 212
GLY A 213
GLY A 223
 ARG  A 703 (-4.3A)
ARG  A 703 (-4.5A)
None
ARG  A 703 ( 3.7A)
ARG  A 703 (-2.6A)
 0.37A 4rn6B-1pq5A:
26.8		 4rn6B-1pq5A:
34.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q3x MANNAN-BINDING
LECTIN SERINE
PROTEASE 2

(Homo sapiens) 		PF00084
(Sushi)
PF00089
(Trypsin) 		5 HIS A 483
VAL A 653
TRP A 655
GLY A 656
GLY A 667
 None
GOL  A 701 (-4.9A)
None
GOL  A 701 ( 4.1A)
GOL  A 701 ( 4.0A)
 0.41A 4rn6B-1q3xA:
30.9		 4rn6B-1q3xA:
34.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qfx PROTEIN (PH 2.5 ACID
PHOSPHATASE)

(Aspergillus
niger) 		PF00328
(His_Phos_2) 		5 LEU A 382
LEU A 415
ALA A 288
ALA A 295
GLY A 330
 None
 1.00A 4rn6B-1qfxA:
undetectable		 4rn6B-1qfxA:
19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qzz ACLACINOMYCIN-10-HYD
ROXYLASE

(Streptomyces
purpurascens) 		PF00891
(Methyltransf_2) 		6 LEU A 187
ALA A 221
ALA A 237
VAL A 236
GLY A 191
GLY A 194
 None
None
None
None
SAM  A 635 ( 3.2A)
ACT  A 421 (-3.4A)
 1.28A 4rn6B-1qzzA:
undetectable		 4rn6B-1qzzA:
21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rbl RIBULOSE 1,5
BISPHOSPHATE
CARBOXYLASE/OXYGENAS
E (LARGE CHAIN)

(Synechococcus
elongatus) 		PF00016
(RuBisCO_large)
PF02788
(RuBisCO_large_N) 		6 LEU A 170
LEU A 455
ALA A 458
ALA A 423
VAL A 384
GLY A 416
 None
 1.29A 4rn6B-1rblA:
undetectable		 4rn6B-1rblA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u1z (3R)-HYDROXYMYRISTOY
L-[ACYL CARRIER
PROTEIN] DEHYDRATASE

(Pseudomonas
aeruginosa) 		PF07977
(FabA) 		5 LEU A  95
LEU A 107
ALA A 127
VAL A 134
GLY A  58
 None
 0.98A 4rn6B-1u1zA:
undetectable		 4rn6B-1u1zA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zjk MANNAN-BINDING
LECTIN SERINE
PROTEASE 2

(Homo sapiens) 		PF00084
(Sushi)
PF00089
(Trypsin) 		5 HIS A 483
VAL A 653
TRP A 655
GLY A 656
GLY A 667
 None
 0.34A 4rn6B-1zjkA:
32.4		 4rn6B-1zjkA:
25.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1zlr COAGULATION FACTOR
XI

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS A  57
ALA A 190
TRP A 215
GLY A 216
GLY A 226
 368  A 901 (-4.0A)
368  A 901 (-3.7A)
None
368  A 901 (-3.6A)
368  A 901 (-3.5A)
 0.93A 4rn6B-1zlrA:
29.1		 4rn6B-1zlrA:
36.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2avn UBIQUINONE/MENAQUINO
NE BIOSYNTHESIS
METHYLTRANSFERASE-RE
LATED PROTEIN

(Thermotoga
maritima) 		PF08241
(Methyltransf_11) 		5 LEU A  47
LEU A  77
ALA A  80
GLY A  51
GLY A  54
 None
None
None
SAI  A1300 (-3.8A)
None
 0.87A 4rn6B-2avnA:
undetectable		 4rn6B-2avnA:
22.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2eek TRYPSIN-1

(Gadus morhua) 		PF00089
(Trypsin) 		5 HIS A  57
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
None
None
BEN  A 301 ( 3.8A)
BEN  A 301 (-3.2A)
 0.29A 4rn6B-2eekA:
27.8		 4rn6B-2eekA:
37.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ei8 COAGULATION FACTOR
X, HEAVY CHAIN

(Homo sapiens) 		PF00089
(Trypsin) 		6 HIS A  57
ALA A 190
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
DT8  A 700 (-3.6A)
DT8  A 700 ( 4.1A)
DT8  A 700 (-3.9A)
DT8  A 700 (-3.5A)
DT8  A 700 (-3.5A)
 0.63A 4rn6B-2ei8A:
30.0		 4rn6B-2ei8A:
40.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2f91 HEPATOPANCREAS
TRYPSIN

(Astacus
leptodactylus) 		PF00089
(Trypsin) 		6 HIS A  57
LEU A  99
VAL A 213
TRP A 215
GLY A 216
GLY A 227
 None
 0.33A 4rn6B-2f91A:
28.8		 4rn6B-2f91A:
36.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fr1 ERYTHROMYCIN
SYNTHASE, ERYAI

(Saccharopolyspora
erythraea) 		PF08659
(KR) 		5 LEU A1685
TRP A1839
ALA A1753
GLY A1678
GLY A1672
 None
None
NDP  A 301 ( 3.7A)
None
NDP  A 301 ( 4.0A)
 1.02A 4rn6B-2fr1A:
undetectable		 4rn6B-2fr1A:
21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gk1 BETA-HEXOSAMINIDASE
SUBUNIT BETA CHAIN A
BETA-HEXOSAMINIDASE
SUBUNIT BETA CHAIN B

(Homo sapiens) 		no annotation 5 LEU N 451
ALA N 506
VAL N 509
GLY M 204
GLY N 484
 None
 1.02A 4rn6B-2gk1N:
undetectable		 4rn6B-2gk1N:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jet CHYMOTRYPSINOGEN B
CHAIN B
CHYMOTRYPSINOGEN B
CHAIN C

(Rattus
norvegicus) 		PF00089
(Trypsin) 		5 HIS B  57
VAL C 213
TRP C 215
GLY C 216
GLY C 226
 None
 0.68A 4rn6B-2jetB:
12.9		 4rn6B-2jetB:
25.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2oq5 TRANSMEMBRANE
PROTEASE, SERINE 11E

(Homo sapiens) 		PF00089
(Trypsin) 		6 HIS A  57
ALA A 190
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
BEN  A 245 (-3.9A)
None
None
BEN  A 245 ( 3.8A)
BEN  A 245 (-3.4A)
 0.84A 4rn6B-2oq5A:
29.3		 4rn6B-2oq5A:
36.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2paa PHOSPHOGLYCERATE
KINASE, TESTIS
SPECIFIC

(Mus musculus) 		PF00162
(PGK) 		5 LEU A 354
ALA A 209
VAL A 334
GLY A 337
GLY A 371
 None
None
None
ATP  A 500 (-3.1A)
None
 0.95A 4rn6B-2paaA:
undetectable		 4rn6B-2paaA:
19.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2pks THROMBIN HEAVY CHAIN
FRAGMENT

(Homo sapiens) 		PF00089
(Trypsin) 		5 ALA C 230
VAL C 255
TRP C 257
GLY C 258
GLY C 268
 G44  C 101 (-3.8A)
None
G44  C 101 (-4.1A)
G44  C 101 (-3.3A)
G44  C 101 (-3.0A)
 0.75A 4rn6B-2pksC:
9.6		 4rn6B-2pksC:
99.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2psy KALLIKREIN-5

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS A  57
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
 0.52A 4rn6B-2psyA:
28.5		 4rn6B-2psyA:
34.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qko POSSIBLE
TRANSCRIPTIONAL
REGULATOR, TETR
FAMILY PROTEIN

(Rhodococcus
jostii) 		PF00440
(TetR_N) 		5 LEU A 109
ALA A  31
ALA A  15
VAL A  18
GLY A  26
 None
 0.96A 4rn6B-2qkoA:
undetectable		 4rn6B-2qkoA:
20.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qy0 COMPLEMENT C1R
SUBCOMPONENT

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS B 485
VAL B 657
TRP B 659
GLY B 660
GLY B 668
 None
 0.29A 4rn6B-2qy0B:
27.7		 4rn6B-2qy0B:
37.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r2w PLASMINOGEN
ACTIVATOR, UROKINASE

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS U  57
VAL U 213
TRP U 215
GLY U 216
GLY U 226
 4PG  U 300 (-3.9A)
None
None
4PG  U 300 (-3.3A)
4PG  U 300 (-3.2A)
 0.32A 4rn6B-2r2wU:
30.3		 4rn6B-2r2wU:
29.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rjo TWIN-ARGININE
TRANSLOCATION
PATHWAY SIGNAL
PROTEIN

(Paraburkholderia
phytofirmans) 		PF13407
(Peripla_BP_4) 		5 LEU A 348
LEU A  43
ALA A  62
GLY A 295
GLY A 292
 None
 0.95A 4rn6B-2rjoA:
undetectable		 4rn6B-2rjoA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vpv PROTEIN MIF2

(Saccharomyces
cerevisiae) 		PF11699
(CENP-C_C) 		5 ALA A 520
ALA A 513
VAL A 485
GLY A 516
GLY A 483
 None
 0.97A 4rn6B-2vpvA:
undetectable		 4rn6B-2vpvA:
22.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2zec TRYPTASE BETA 2

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS A  59
VAL A 227
TRP A 229
GLY A 230
GLY A 240
 None
None
None
11N  A   1 (-3.9A)
11N  A   1 (-3.6A)
 0.48A 4rn6B-2zecA:
28.0		 4rn6B-2zecA:
35.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3beu TRYPSIN

(Streptomyces
griseus) 		PF00089
(Trypsin) 		5 HIS A  57
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 SO4  A 246 ( 3.8A)
None
None
BEN  A 247 (-3.7A)
BEN  A 247 (-3.5A)
 0.29A 4rn6B-3beuA:
26.5		 4rn6B-3beuA:
30.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3f6u VITAMIN K-DEPENDENT
PROTEIN C HEAVY
CHAIN

(Homo sapiens) 		PF00089
(Trypsin) 		6 HIS H  57
ALA H 190
VAL H 213
TRP H 215
GLY H 216
GLY H 226
 0G6  H   1 (-3.2A)
0G6  H   1 (-3.4A)
None
0G6  H   1 (-4.1A)
0G6  H   1 (-3.8A)
0G6  H   1 ( 3.9A)
 0.91A 4rn6B-3f6uH:
30.6		 4rn6B-3f6uH:
36.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fht ATP-DEPENDENT RNA
HELICASE DDX19B

(Homo sapiens) 		PF00270
(DEAD)
PF00271
(Helicase_C) 		5 LEU A  99
ALA A 146
VAL A 149
GLY A 106
GLY A 186
 None
ANP  A 480 ( 4.6A)
None
None
None
 0.78A 4rn6B-3fhtA:
undetectable		 4rn6B-3fhtA:
23.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gov MASP-1

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS B 490
ALA B 641
VAL B 666
TRP B 668
GLY B 669
 None
 0.85A 4rn6B-3govB:
30.1		 4rn6B-3govB:
36.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gov MASP-1

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS B 490
VAL B 666
TRP B 668
GLY B 669
GLY B 679
 None
 0.44A 4rn6B-3govB:
30.1		 4rn6B-3govB:
36.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3gym PROSTASIN

(Homo sapiens) 		PF00089
(Trypsin) 		6 HIS A  57
ALA A 190
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
 0.79A 4rn6B-3gymA:
28.3		 4rn6B-3gymA:
36.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i4j AMINOTRANSFERASE,
CLASS III

(Deinococcus
radiodurans) 		PF00202
(Aminotran_3) 		5 ALA A 101
ALA A  94
VAL A  95
GLY A 260
GLY A  98
 None
None
None
None
SO4  A 431 (-3.6A)
 0.98A 4rn6B-3i4jA:
undetectable		 4rn6B-3i4jA:
20.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3nxp PRETHROMBIN-1

(Homo sapiens) 		PF00051
(Kringle)
PF00089
(Trypsin)
PF09396
(Thrombin_light) 		5 HIS A 457
TYR A 460
LEU A 499
VAL A 613
GLY A 626
 None
 0.50A 4rn6B-3nxpA:
36.6		 4rn6B-3nxpA:
99.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3nxp PRETHROMBIN-1

(Homo sapiens) 		PF00051
(Kringle)
PF00089
(Trypsin)
PF09396
(Thrombin_light) 		5 HIS A 457
TYR A 460
TRP A 460
LEU A 499
GLY A 626
 None
 0.88A 4rn6B-3nxpA:
36.6		 4rn6B-3nxpA:
99.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3r3g THROMBIN HEAVY CHAIN

(Homo sapiens) 		PF00089
(Trypsin) 		8 HIS B  57
TYR B  60
LEU B  99
ALA B 190
VAL B 213
TRP B 215
GLY B 216
GLY B 226
 None
 0.77A 4rn6B-3r3gB:
36.6		 4rn6B-3r3gB:
97.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3r3g THROMBIN HEAVY CHAIN

(Homo sapiens) 		PF00089
(Trypsin) 		6 TYR B  60
TRP B  60
LEU B  99
TRP B 215
GLY B 216
GLY B 226
 None
 0.78A 4rn6B-3r3gB:
36.6		 4rn6B-3r3gB:
97.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s6h N-ACETYLGLUTAMATE
KINASE /
N-ACETYLGLUTAMATE
SYNTHASE

(Maricaulis
maris) 		PF00696
(AA_kinase)
PF04768
(NAT) 		5 LEU A  57
ALA A 191
VAL A  74
GLY A  46
GLY A  76
 None
 1.02A 4rn6B-3s6hA:
undetectable		 4rn6B-3s6hA:
19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slk POLYKETIDE SYNTHASE
EXTENDER MODULE 2

(Saccharopolyspora
spinosa) 		PF08240
(ADH_N)
PF08659
(KR)
PF13602
(ADH_zinc_N_2) 		5 LEU A 529
TRP A 682
ALA A 598
GLY A 522
GLY A 516
 None
None
NDP  A 802 (-3.8A)
None
NDP  A 802 (-3.3A)
 0.93A 4rn6B-3slkA:
undetectable		 4rn6B-3slkA:
15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t61 GLUCONOKINASE

(Sinorhizobium
meliloti) 		PF01202
(SKI) 		5 LEU A 175
LEU A  81
ALA A 106
GLY A  17
GLY A 109
 None
 0.95A 4rn6B-3t61A:
undetectable		 4rn6B-3t61A:
23.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsd INOSINE-5'-MONOPHOSP
HATE DEHYDROGENASE

(Bacillus
anthracis) 		PF00478
(IMPDH)
PF00571
(CBS) 		5 LEU A 363
LEU A 321
ALA A 323
ALA A 353
GLY A 301
 None
 0.98A 4rn6B-3tsdA:
undetectable		 4rn6B-3tsdA:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a3q ALANINE RACEMASE 1

(Staphylococcus
aureus) 		PF00842
(Ala_racemase_C)
PF01168
(Ala_racemase_N) 		5 LEU A 128
LEU A  67
ALA A  70
ALA A  96
VAL A 101
 None
 0.99A 4rn6B-4a3qA:
undetectable		 4rn6B-4a3qA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4at0 3-KETOSTEROID-DELTA4
-5ALPHA-DEHYDROGENAS
E

(Rhodococcus
jostii) 		PF00890
(FAD_binding_2) 		5 ALA A 486
ALA A 453
VAL A 237
GLY A 450
GLY A 235
 None
 0.90A 4rn6B-4at0A:
undetectable		 4rn6B-4at0A:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bxw FACTOR XA

(Pseudonaja
textilis) 		PF00089
(Trypsin)
PF14670
(FXa_inhibition) 		5 HIS A 211
ALA A 357
VAL A 380
GLY A 383
GLY A 393
 0GJ  A1411 (-2.8A)
0GJ  A1411 (-3.4A)
None
0GJ  A1411 (-3.7A)
0GJ  A1411 (-3.3A)
 0.84A 4rn6B-4bxwA:
29.1		 4rn6B-4bxwA:
27.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fxg MANNAN-BINDING
LECTIN SERINE
PROTEASE 2 B CHAIN

(Homo sapiens) 		PF00089
(Trypsin) 		6 HIS H 483
ALA H 633
VAL H 653
TRP H 655
GLY H 656
GLY H 667
 None
 0.58A 4rn6B-4fxgH:
30.0		 4rn6B-4fxgH:
35.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gj1 1-(5-PHOSPHORIBOSYL)
-5-[(5-PHOSPHORIBOSY
LAMINO)METHYLIDENEAM
INO]
IMIDAZOLE-4-CARBOXAM
IDE ISOMERASE

(Campylobacter
jejuni) 		PF00977
(His_biosynth) 		5 LEU A 169
LEU A  53
ALA A  56
GLY A  81
GLY A  83
 None
 1.01A 4rn6B-4gj1A:
undetectable		 4rn6B-4gj1A:
22.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h4f CHYMOTRYPSIN-C

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS A  57
LEU A  99
ALA A 190
VAL A 213
GLY A 216
 None
 0.72A 4rn6B-4h4fA:
28.6		 4rn6B-4h4fA:
30.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hzh PROTHROMBIN

(Homo sapiens) 		PF00051
(Kringle)
PF00089
(Trypsin)
PF09396
(Thrombin_light) 		7 HIS A 363
TYR A 367
TRP A 370
ALA A 525
VAL A 545
GLY A 548
GLY A 558
 None
 1.04A 4rn6B-4hzhA:
36.9		 4rn6B-4hzhA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hzh PROTHROMBIN

(Homo sapiens) 		PF00051
(Kringle)
PF00089
(Trypsin)
PF09396
(Thrombin_light) 		7 HIS A 363
TYR A 367
TRP A 370
LEU A 416
ALA A 525
VAL A 545
GLY A 558
 None
 0.73A 4rn6B-4hzhA:
36.9		 4rn6B-4hzhA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ia5 MYOSIN-CROSSREACTIVE
ANTIGEN

(Lactobacillus
acidophilus) 		PF06100
(MCRA) 		5 TYR A  94
LEU A 232
ALA A 516
GLY A  31
GLY A  29
 None
 0.91A 4rn6B-4ia5A:
undetectable		 4rn6B-4ia5A:
18.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4iw4 MANNAN-BINDING
LECTIN SERINE
PROTEASE 3

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS E 478
VAL E 665
TRP E 667
GLY E 668
GLY E 680
 None
 0.34A 4rn6B-4iw4E:
28.9		 4rn6B-4iw4E:
31.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kkd MANNAN-BINDING
LECTIN SERINE
PROTEASE 1

(Homo sapiens) 		PF00084
(Sushi)
PF00089
(Trypsin) 		5 HIS A 497
VAL A 684
TRP A 686
GLY A 687
GLY A 699
 None
 0.49A 4rn6B-4kkdA:
31.0		 4rn6B-4kkdA:
26.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lk4 VESB PROTEASE

(Vibrio cholerae) 		PF00089
(Trypsin) 		7 HIS A  78
LEU A 122
ALA A 221
VAL A 237
TRP A 239
GLY A 240
GLY A 251
 None
 0.66A 4rn6B-4lk4A:
24.9		 4rn6B-4lk4A:
28.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4r0i SUPPRESSOR OF
TUMORIGENICITY 14
PROTEIN

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS A  57
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 3KM  A 900 ( 4.4A)
None
None
3KM  A 900 (-3.4A)
3KM  A 900 (-3.2A)
 0.35A 4rn6B-4r0iA:
30.4		 4rn6B-4r0iA:
31.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rk0 LACI FAMILY
SUGAR-BINDING
TRANSCRIPTIONAL
REGULATOR

(Enterococcus
faecalis) 		PF13377
(Peripla_BP_3) 		5 LEU A 224
LEU A 255
ALA A 246
VAL A 193
GLY A 228
 None
 1.02A 4rn6B-4rk0A:
undetectable		 4rn6B-4rk0A:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u48 PUTATIVE INNER
MEMBRANE LIPOPROTEIN

(Salmonella
enterica) 		PF00207
(A2M)
PF01835
(A2M_N)
PF07703
(A2M_N_2)
PF10569
(Thiol-ester_cl)
PF11974
(MG1) 		5 LEU A 853
ALA A 994
VAL A 886
GLY A 973
GLY A 975
 None
 1.02A 4rn6B-4u48A:
undetectable		 4rn6B-4u48A:
10.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wwy TRYPSIN-1

(Homo sapiens) 		PF00089
(Trypsin) 		6 HIS A  57
LEU A  99
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
 0.63A 4rn6B-4wwyA:
28.5		 4rn6B-4wwyA:
36.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ylq COAGULATION FACTOR
VII

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS H  57
VAL H 213
TRP H 215
GLY H 216
GLY H 226
 0Z7  H 501 (-2.6A)
0Z7  H 501 ( 4.7A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
 0.33A 4rn6B-4ylqH:
29.5		 4rn6B-4ylqH:
35.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ysw XANTHINE
DEHYDROGENASE/OXIDAS
E

(Rattus
norvegicus) 		PF00111
(Fer2)
PF00941
(FAD_binding_5)
PF01315
(Ald_Xan_dh_C)
PF01799
(Fer2_2)
PF02738
(Ald_Xan_dh_C2)
PF03450
(CO_deh_flav_C) 		5 LEU A1098
LEU A1031
ALA A1019
ALA A1050
GLY A1131
 None
 1.02A 4rn6B-4yswA:
undetectable		 4rn6B-4yswA:
12.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5brr TISSUE-TYPE
PLASMINOGEN
ACTIVATOR

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS E  57
ALA E 190
ALA E 195
TRP E 215
GLY E 216
 None
 0.98A 4rn6B-5brrE:
29.2		 4rn6B-5brrE:
32.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5brr TISSUE-TYPE
PLASMINOGEN
ACTIVATOR

(Homo sapiens) 		PF00089
(Trypsin) 		5 HIS E  57
ALA E 195
TRP E 215
GLY E 216
GLY E 226
 None
 0.52A 4rn6B-5brrE:
29.2		 4rn6B-5brrE:
32.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d68 KREV INTERACTION
TRAPPED PROTEIN 1

(Homo sapiens) 		PF00373
(FERM_M)
PF13857
(Ank_5) 		5 LEU A 411
ALA A 407
VAL A 371
GLY A 364
GLY A 366
 None
 0.98A 4rn6B-5d68A:
undetectable		 4rn6B-5d68A:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5do7 ATP-BINDING CASSETTE
SUB-FAMILY G MEMBER
5

(Homo sapiens) 		PF00005
(ABC_tran)
PF01061
(ABC2_membrane) 		5 LEU A 518
ALA A 438
ALA A 468
GLY A 513
GLY A 434
 None
 1.02A 4rn6B-5do7A:
undetectable		 4rn6B-5do7A:
17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ds0 PEPTIDASE M42

(Thaumarchaeota
archaeon SCGC
AB-539-E09) 		PF05343
(Peptidase_M42) 		5 LEU A 292
LEU A 342
ALA A 283
GLY A 261
GLY A 259
 None
 0.96A 4rn6B-5ds0A:
undetectable		 4rn6B-5ds0A:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ejh NAD KINASE 1

(Listeria
monocytogenes) 		PF01513
(NAD_kinase) 		6 TYR A 236
LEU A 209
LEU A 167
ALA A 185
GLY A 151
GLY A 149
 None
 1.48A 4rn6B-5ejhA:
undetectable		 4rn6B-5ejhA:
22.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fah KALLIKREIN-7

(Homo sapiens) 		PF00089
(Trypsin) 		5 ALA A 190
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 5VT  A 302 (-3.8A)
None
None
5VT  A 302 (-3.4A)
5VT  A 302 ( 4.3A)
 0.90A 4rn6B-5fahA:
25.9		 4rn6B-5fahA:
30.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ffn ENZYME SUBTILASE
SUBTY FROM BACILLUS
SP. TY145

(Bacillus sp.
(in: Bacteria)) 		PF00082
(Peptidase_S8) 		5 TYR A 240
TRP A 239
VAL A 105
GLY A 110
GLY A 112
 None
 1.02A 4rn6B-5ffnA:
undetectable		 4rn6B-5ffnA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fg3 PROBABLE TRANSLATION
INITIATION FACTOR
IF-2

(Aeropyrum
pernix) 		PF00009
(GTP_EFTU)
PF03144
(GTP_EFTU_D2)
PF11987
(IF-2)
PF14578
(GTP_EFTU_D4) 		5 LEU A 129
ALA A 108
VAL A  20
GLY A  23
GLY A  90
 None
 1.00A 4rn6B-5fg3A:
undetectable		 4rn6B-5fg3A:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gxf ACRYLYL-COA
REDUCTASE ACUI

(Ruegeria
pomeroyi) 		PF00107
(ADH_zinc_N) 		5 LEU A 193
ALA A 223
ALA A 134
GLY A 160
GLY A 157
 None
None
None
None
BR  A 401 (-3.6A)
 1.02A 4rn6B-5gxfA:
undetectable		 4rn6B-5gxfA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hk8 PROBABLE
PHEOPHORBIDASE

(Arabidopsis
thaliana) 		PF12697
(Abhydrolase_6) 		5 TYR A  64
LEU A 189
LEU A  83
ALA A  96
GLY A  90
 None
 1.02A 4rn6B-5hk8A:
undetectable		 4rn6B-5hk8A:
21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ifz RIBOSE 5-PHOSPHATE
ISOMERASE

(Brucella
melitensis) 		PF02502
(LacAB_rpiB) 		5 LEU A  58
ALA A 121
ALA A  28
VAL A  77
GLY A  79
 None
 1.02A 4rn6B-5ifzA:
undetectable		 4rn6B-5ifzA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jr3 CARMINOMYCIN
4-O-METHYLTRANSFERAS
E DNRK

(Streptomyces
peucetius) 		PF00891
(Methyltransf_2) 		5 LEU A 184
ALA A 218
VAL A 233
GLY A 188
GLY A 191
 None
None
SO4  A 405 (-3.7A)
SAH  A 401 ( 3.7A)
None
 0.90A 4rn6B-5jr3A:
undetectable		 4rn6B-5jr3A:
21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l26 NUCLEOSIDE PERMEASE

(Neisseria
wadsworthii) 		PF01773
(Nucleos_tra2_N)
PF07662
(Nucleos_tra2_C)
PF07670
(Gate) 		5 LEU A 406
LEU A 220
ALA A 217
GLY A 401
GLY A 213
 None
 0.99A 4rn6B-5l26A:
undetectable		 4rn6B-5l26A:
18.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5o32 COMPLEMENT FACTOR I

(Homo sapiens) 		PF00089
(Trypsin) 		6 HIS I 380
ALA I 520
VAL I 544
TRP I 546
GLY I 547
GLY I 557
 None
 0.74A 4rn6B-5o32I:
27.8		 4rn6B-5o32I:
32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5to3 PROTHROMBIN,THROMBOM
ODULIN

(Homo sapiens) 		PF00089
(Trypsin)
PF09064
(Tme5_EGF_like) 		6 HIS B  58
LEU B 111
ALA B 215
VAL B 240
GLY B 243
GLY B 253
 0G6  B 501 (-2.5A)
0G6  B 501 ( 3.8A)
0G6  B 501 (-3.4A)
None
0G6  B 501 (-3.7A)
0G6  B 501 (-3.6A)
 0.76A 4rn6B-5to3B:
37.7		 4rn6B-5to3B:
88.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5to3 PROTHROMBIN,THROMBOM
ODULIN

(Homo sapiens) 		PF00089
(Trypsin)
PF09064
(Tme5_EGF_like) 		6 HIS B  58
TYR B  62
LEU B 111
VAL B 240
GLY B 243
GLY B 253
 0G6  B 501 (-2.5A)
0G6  B 501 (-3.7A)
0G6  B 501 ( 3.8A)
None
0G6  B 501 (-3.7A)
0G6  B 501 (-3.6A)
 0.35A 4rn6B-5to3B:
37.7		 4rn6B-5to3B:
88.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ubm COMPLEMENT C1S
SUBCOMPONENT

(Homo sapiens) 		no annotation 5 HIS A 475
VAL A 653
TRP A 655
GLY A 656
GLY A 663
 None
 0.48A 4rn6B-5ubmA:
27.1		 4rn6B-5ubmA:
35.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xd6 PROTEIN KINASE
SUPERFAMILY PROTEIN

(Arabidopsis
thaliana) 		no annotation 6 HIS A 197
ALA A 213
ALA A 216
VAL A 205
GLY A 183
GLY A 179
 None
None
MG  A1001 ( 4.4A)
None
None
None
 1.46A 4rn6B-5xd6A:
undetectable		 4rn6B-5xd6A:
14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ya1 AUTOINDUCER-2 KINASE

(Escherichia
coli) 		no annotation 5 LEU A 179
ALA A 463
ALA A  86
VAL A 248
GLY A 250
 None
 0.97A 4rn6B-5ya1A:
undetectable		 4rn6B-5ya1A:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zfh KALLIKREIN-7

(Mus musculus) 		no annotation 5 HIS A  57
VAL A 213
TRP A 215
GLY A 216
GLY A 226
 None
 0.38A 4rn6B-5zfhA:
27.2		 4rn6B-5zfhA:
16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b74 COAGULATION FACTOR
XII

(Homo sapiens) 		no annotation 5 HIS B  57
ALA B 190
TRP B 215
GLY B 216
GLY B 226
 SO4  B 304 (-3.8A)
BEN  B 301 (-4.1A)
None
BEN  B 301 (-3.3A)
BEN  B 301 (-3.1A)
 0.71A 4rn6B-6b74B:
29.1		 4rn6B-6b74B:
15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bj9 ACETYL-COA
ACETYLTRANSFERASE A

(Ascaris suum) 		no annotation 5 ALA A  97
ALA A  86
VAL A  87
GLY A 117
GLY A  94
 None
 1.02A 4rn6B-6bj9A:
undetectable		 4rn6B-6bj9A:
15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bn2 ACETYL-COA
ACETYLTRANSFERASE

(Elizabethkingia
anophelis) 		no annotation 5 ALA A  94
ALA A  83
VAL A  84
GLY A 114
GLY A  91
 None
 0.99A 4rn6B-6bn2A:
undetectable		 4rn6B-6bn2A:
15.55